Angeles Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Angeles Wealth Management's PFE Position: Q3 2026 in Review
Angeles Wealth Management reduced its Pfizer (PFE) stake by 13% in Q3 2026, selling an estimated $57.7K and leaving 14,841 shares worth $423K. The position accounts for 0.02% of the portfolio, ranked #296.
Angeles Wealth Management first reported a position in PFE in Q1 2022 and has held it in 19 quarters since. The position peaked at $787K in Q4 2022. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Angeles Wealth Management held 14,841 shares of Pfizer worth $423K as of Q3 2026.
- Angeles Wealth Management sold 2,168 Pfizer shares in Q3 2026, an estimated $57.7K.
- Pfizer made up 0.02% of Angeles Wealth Management's portfolio in Q3 2026, its #296 holding.
- Angeles Wealth Management first reported a position in Pfizer in Q1 2022 and has held it in 19 quarters since.
- Angeles Wealth Management's Pfizer position peaked at $787K in Q4 2022.
- 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Angeles Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.